Neurological Events Reported after COVID-19 Vaccines: An Analysis of VAERS.

ABSTRACT:

Objective

To identify the rates of neurological events following administration of mRNA (Pfizer, Moderna) or adenovirus vector (Janssen) vaccines in the U.S..

Methods

We utilized publicly available data from the U.S. Vaccine Adverse Event Reporting System (VAERS) collected between January 1, 2021-June 14, 2021. All free text symptoms that were reported within 42 days of vaccine administration were manually reviewed and grouped into 36 individual neurological diagnostic categories. Post-vaccination neurological event rates were compared between vaccine types and to age-matched baseline incidence rates in the U.S. and rates of neurological events following COVID.

Results

Of 306,907,697 COVID vaccine doses administered during the study timeframe, 314,610 (0.1%) people re

SUBMITTER: Frontera JA 

PROVIDER: S-EPMC9082459 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature